Humacyte director reports 156,519 shares held directly

Humacyte, Inc. director Paul Brian Kuznik reported 156,519 shares of common stock held directly and 65,719 shares held by his spouse, as of September 22, 2026.

Rhea-AI Filing Summary

Humacyte, Inc. director Paul Brian Kuznik reported 156,519 shares of common stock held directly and 65,719 shares held by his spouse, as of September 22, 2026.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kuznik Paul Brian

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 65,719 shares (Indirect, By spouse); Common Stock — 156,519 shares (Direct)

Key Figures

Common shares held directly: 156,519 shares Common shares held by spouse: 65,719 shares

2 metrics

Common shares held directly 156,519 shares Reported September 22, 2026

Common shares held by spouse 65,719 shares Reported September 22, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Humacyte (HUMA) shares did director Paul Brian Kuznik report?

Paul Brian Kuznik reported 156,519 shares held directly and 65,719 shares held by his spouse, as of September 22, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 04:08 PM Accepted by SEC EDGAR 09/28/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kuznik Paul Brian

(Last) (First) (Middle)

2525 EAST NORTH CAROLINA HIGHWAY 54

(Street)

DURHAM NORTH CAROLINA 27713

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/22/2026

3. Issuer Name and Ticker or Trading Symbol
Humacyte, Inc. [ HUMA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	65,719	I	By spouse
Common Stock	156,519	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24.1 Power of Attorney

	/s/ Paul B. Kuznik by Dale A. Sander as Attorney-in-Fact	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)